地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172431432
传真:15172431432
邮箱:sales@amyjet.com

Roboz Surgical Instrument公司一直为研究人员提供专门的、手工制作的外科器械,以满足他们独特的需求。Roboz Surgical Instrument公司是外科器械和相关产品的领先设计师和开发商,产品被世界各地的医疗保健和研究专业人士使用。
When Otto Roboz started the Roboz Surgical Instrument Company in 1953, his goal was to provide researchers with specialized, hand-crafted surgical instruments designed to meet their unique demands. Since then, Roboz Surgical has grown into one of the life science market’s leading sources of quality surgical instruments. Although the work of the research community has changed quite a bit over the last 60 years, Roboz Surgical, through constant innovation, continues to provide the highest-quality instruments and unparalleled service, to meet and exceed all of our customers’ needs.
Today Roboz Surgical Instrument Company is a leading designer and developer of surgical instruments and related products. Our products are used by healthcare and research professionals worldwide. Throughout our history of over sixty years , the Roboz name has been synonymous with quality.
Roboz Surgical Instrument公司主要产品:
Bone Instruments
Clips & Clamps
General Micro Dissecting
Instrument Care and
Handling
Instrument Services
Misc. Instruments
Retractors
Scalpels
Scissors
Tweezers & Forceps
Vascular Access
Wound Closures
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://antylia.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Roboz Surgical Instrument"> Roboz Surgical Instrument
艾美捷科技代理SynQuest品牌
SynQuest成立于1994年,专注于氟化有机和无机化学品,提供创造性和创新性的构建模块,试剂以及压缩和液化气体。
▍SynQuest公司的关键业务
● 电子材料: 高纯硅烷(99.9999%); 蚀刻气体NF₃/ClF₃(水分≤0.5 ppm);
● 分析科学:特色产品线包含 VOC检测标准品(EPA 8260系列); POPs持久污染物标样(符合斯德哥尔摩公约)。技术亮点:-86℃深冷存储保证稳定性;
● 定制合成:氘代化合物(D>99.5%);手性化合物(ee值>99.9%),可克级至吨级柔性生产。

▍SynQuest公司的主要产品
● 超高纯度化学品(纯度≥99.999%)
● 环境分析标准品(EPA/SOT合规)
● 半导体材料(光刻胶前驱体/蚀刻气体)
● 同位素标记化合物(¹³C/¹⁵N/²H标记率>99%)
▍SynQuest部分产品列表
| 品名 | 货号 | CAS号 | 分子量 | 分子式 | 纯度 | 规格 |
| 1,1,2,2-Tetrafluoroethane | 1100-3-10 | 359-35-3 | 102.032 | C2H2F4 | 98% | 5 g;25 g;Bulk |
| 1,1,1,2,3,3-Hexafluoropropane | 1100-3-27 | 431-63-0 | 152.039 | C3H2F6 | 98% | 100 g;250g;Bulk |
| 1,2,2,3-Tetrachloropropane | 1100-5-23 | 13116-53-5 | 181.87 | C3H4Cl4 | 99% | 5 g;25 g;Bulk |
| 1,2-Dichlorohexafluoropropane | 1100-6-19 | 661-97-2 | 220.92 | C3Cl2F6 | 100% | 5 g;25 g;Bulk |
| 1,2,3-Trichloropentafluoropropane | 1100-6-22 | 76-17-5 | 237.38 | C3Cl3F5 | 99% | 5 g;25 g;Bulk |
| 1,1-Dichloro-1-fluoroethane | 1100-7-21 | 1717-00-6 | 116.94 | C2H3Cl2F | 98% | 100 g;250g;Bulk |
| 3-Chloro-1,1,1-trifluoropropane | 1100-7-29 | 460-35-5 | 132.51 | C3H4ClF3 | 98% | 100 g;Bulk |
| 1-Bromoperfluorononane | 1100-A-16 | 558-96-3 | 548.973 | C9BrF19 | 98% | 5 g;25 g;Bulk |
| 1,2-Dibromo-3-fluoropropane | 1100-B-28 | 453-00-9 | 219.879 | C3H5Br2F | 98% | 1 g;5 g;Bulk |
| 1,2-Dibromo-2,3-dichloropropane | 1100-D-23 | 70289-31-5 | 270.77 | C3H4Br2Cl2 | 98% | 5 g;25 g;Bulk |
| 1,2-Dibromo-1-chlorotrifluoroethane | 1100-E-04 | 354-51-8 | 276.28 | C2Br2ClF3 | 98% | 100 g;Bulk |
| 1-Iodoperfluorodecane | 1100-J-17 | 423-62-1 | 645.981 | C10F21I | 98% | 25 g;100 g;Bulk |
| 1-Iodoperfluoropentane | 1100-J-51 | 638-79-9 | 395.942 | C5F11I | 98% | 5g;25 g;Bulk |
| Cyclopropane | 1200-1-03 | 75-19-4 | 42.081 | C3H6 | 99% | 5 g;25 g;Bulk |
| (E)-1,1,1,3-Tetrafluoro-2-butene | 1300-3-46 | 791616-87-0 | 128.07 | C4H4F4 | 98% | 5 g;25 g;Bulk |
| (Z)-1,1,1,3-Tetrafluoro-2-butene | 1300-3-47 | 791616-88-1 | 128.07 | C4H4F4 | 98% | 5 g;25 g;Bulk |
| 2,3-Dichloroprop-1-ene | 1300-5-15 | 78-88-6 | 110.97 | C3H4Cl2 | 98% | 100 g;250g;Bulk |
| 2,3-Dichlorohexafluorobutene-2 | 1300-6-08 | 303-04-8 | 232.93 | C4Cl2F6 | 98% | 25 g;100 g;Bulk |
| Bromotrifluoroethylene, inhibited | 1300-A-01 | 598-73-2 | 160.921 | C2BrF3 | 98% | 5 g;25 g;Bulk |
| 2-Bromo-1,1-difluoroethylene | 1300-B-01 | 359-08-0 | 142.931 | C2HBrF2 | 98% | 5 g;25 g;100g;Bulk |
| Hexafluoro-2-butyne | 1500-2-02 | 692-50-2 | 162.034 | C4F6 | 98% | 5 g;25 g;100g;Bulk |
| 3,3,3-Trifluoropropyne | 1500-3-02 | 661-54-1 | 94.036 | C3HF3 | 98% | 5 g;25 g;Bulk |

艾美捷科技代理3Helix品牌胶原蛋白杂交肽(CHP)。
胶原蛋白是几乎存在于所有人体组织中,在支持细胞生长和组织形成方面发挥着重要作用。胶原蛋白受损预示着结缔组织的损伤,也是多种涉及炎症和异常组织重塑的疾病的征兆,例如癌症、
心肌梗塞、关节炎、骨质疏松症和纤维化。然而,用传统技术很难定位受损的胶原蛋白。因此,3Helix公司开发了一系列专利性的胶原蛋白杂交肽,可直接定位受损的胶原蛋白分子。
3Helix产品包括:
(1)Auto-CHP:胶原蛋白杂交肽,用于自动染色的生物素结合物;
(2)B-CHP:胶原蛋白杂交肽,生物素结合物;
(3)F-CHP:胶原蛋白杂交肽,5-FAM 结合物;
(4)In vivo:胶原蛋白杂交肽,磺基-Cy7.5 结合物 (sCy7.5-CHP);
(5)R-CHP:胶原蛋白杂交肽,Cy3 结合物。
< " data-original="http://antylia.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理3Helix品牌胶原蛋白杂交肽"> 艾美捷科技代理3Helix品牌胶原蛋白杂交肽
艾美捷科技代理Peptides.de品牌全系列产品
Peptides.de是一家专注于高质量肽产品生产的的德国企业。公司创立于2001年,总部位于德国赫尼希斯多夫。从单一肽到百万级肽库,从线性链到环状结构,从短肽到超长序列,从粗品到高纯精肽,从修饰化到标记化,从天然氨基酸到非天然变体,Peptides.de提供全维度肽与肽模拟物解决方案,覆盖新抗原筛选、过继性免疫治疗、T细胞刺激实验、表位作图、ELISpot检测、药物发现及芯片技术等核心领域。
Peptides.de公司不仅生产肽,还自主开发用于肽合成的核心设备——肽合成机器人。凭借其专利技术超声肽合成平台 (USPS®),团队能够在短时间高效生产数百种肽,并精准实现客户所需的各种修饰。

▍ReVacc Scientific公司产品
Peptides.de核心业务涵盖:目录肽现货供应、专属肽链定制合成、个性化肽池构建、高通量肽库开发、肽芯片制备服务、功能型修饰肽生产以及精密预分装服务。

▍Peptides.de部分产品列表
| 品名 | 货号 | 规格 |
| ADV hexon (HLA-B*35:01) | EP07882_1 | 1 mg;5 mg |
| ADV hexon 114 -124 (HLA-B*07:02) | EP07881_1 | 1 mg;5 mg |
| ADV hexon 37-45 (HLA-A*24:02) | EP07880_1 | 1 mg;5 mg |
| ADV hexon 886-894 (HLA-A*01:01) | EP10774_1 | 1 mg;5 mg |
| ADV Hexon 917-925 (HLA-A*02:01) | EP07914_1 | 1 mg;5 mg |
| BKV VP1 108-116 (HLA-A*02:01) | EP11456_1 | 1 mg;5 mg |
| BRLF1 109-117 (HLA-A*02:01) | EP11139_1 | 1 mg;5 mg |
| Chlamydia trachomatis MOMP 258-266 (HLA-A*02:01) | EP11114_1 | 1 mg;5 mg |
| EBNA 3a (596-604) | EP10789_1 | 1 mg;5 mg |
| EBNA-1 Protein (562-570) | EP04510_1 | 1 mg;5 mg |
| EBV BALF-4 276-284 (HLA-A*02:01) | EP11237_1 | 1 mg;5 mg |
| EBV BMLF-1 280-288 (HLA-A*02:01) | EP07604_1 | 1 mg;5 mg |
| EBV BMRF1 116-128 (HLA-B*07:02) | EP11138_1 | 1 mg;5 mg |
| EBV BMRF1 208-216 (HLA-A*02:01) | EP11127_1 | 1 mg;5 mg |
| EBV BRLF-1 148-156 (HLA-A*03:01) | EP11482_1 | 1 mg;5 mg |
| EBV BRLF1 101-109 (HLA-A*29:02) | EP11142_1 | 1 mg;5 mg |
| EBV BRLF1 134-142 (HLA-A*11:01) | EP11140_1 | 1 mg;5 mg |
| EBV BRLF1 28-37 (HLA-A*24:02) | EP11141_1 | 1 mg;5 mg |
| EBV BZLF-1 190-197 (HLA-B*08:01) | EP07899_1 | 1 mg;5 mg |
| EBV BZLF-1 54-64 (HLA-B*35:01) | EP11143_1 | 1 mg;5 mg |
| EBV BZLF-1 54-64 mutant (HLA-B*35:01) | EP11144_1 | 1 mg;5 mg |
| EBV BZLF1 44-52 (HLA-B*07:02) | EP11214_1 | 1 mg;5 mg |
| EBV EBNA 3A 246-253 (HLA-A*24:02) | EP11147_1 | 1 mg;5 mg |
| EBV EBNA 3B 399-408 (HLA-A*11:01) | EP11150_1 | 1 mg;5 mg |

GenWay公司是为了探索和开发人类蛋白组而成立的。公司的总任务就是用基因特异性抗体來筛选和鉴定新蛋白、其功能及其编码基因,旨在成为以抗体介导的蛋白组研发的领域先锋。基因纬公司已成功地发展出一套有自己知识产权的、新穎、高效、低耗、高筛选通量的鉴定方法――抗体介导的蛋白和基因鉴定。公司提供大量的高质量的蛋白和相应的鸡抗体产品,是蛋白质组学研究的重要工具和有力助手。
As a leading protein and antibody solutions provider, GenWay has a proprietary technology platform and an international network to provide our clients with solutions and applications for proteins, antibodies, assays, and cell lines. We specialize in recombinant proteins and domain-specific IgY (chicken) antibodies and their applications, such as Seppro® products and difficult-to-express proteins. GenWay’s technology and expertise make high-quality protein antigens that enable production of high-quality antibodies and related applications.
GenWay Biotech的主要产品包括:
Proteins
Antibodies
ELISA Kits
Secondary Antibodies
Reagents
Peptides
Molecular Biology Products
Active Proteins
Enzymatic Assays
PCR Kits
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://antylia.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="GenWay Biotech"> GenWay Biotech
艾美捷科技代理Svar Life Science品牌。
Svar Life Science 是一家专注于生物技术和生命科学研究工具的公司,提供高质量的诊断试剂、抗体和生物分析工具,支持基础研究、临床诊断和药物开发。Svar Life Science采用先进的生产和质控技术,确保产品的高质量和一致性;产品广泛应用于基础研究、临床诊断和药物开发。应用领域包括:免疫学、细胞生物学和分子生物学研究;用于疾病诊断、生物标志物检测和健康监测;用于药物筛选、药效评估和毒性测试;用于生物制药、疫苗开发和生物材料研究。
Svar Life Science产品和服务包括:
(1)诊断试剂:提供多种用于临床诊断的试剂盒,包括免疫分析试剂盒和分子诊断试剂盒。
(2)抗体:提供多种高特异性和高灵敏度的抗体,用于免疫学研究和诊断。
(3)生物分析工具:提供多种生物分析工具,如ELISA试剂盒、蛋白质印迹试剂和细胞分析试剂。
(4)定制服务:根据客户需求,提供定制化的诊断试剂和抗体开发服务。
<艾美捷科技代理Terracebiotech品牌全系列产品
Terracebiotech的专业技术源于加州大学旧金山分校医学中心的肺研究小组,该小组曾助力明确肺表面活性物质的特性,随后研发出其合成形式,用于治疗患有呼吸窘迫综合征的早产儿。凭借在肺细胞生物学领域超过 25 年的实践研究经验,Terracebiotech将其专业技术应用于推动医学研究的进一步创新,以改善人类健康。
Terracebiotech的抗体(在人体肺部中特异性靶向肺泡上皮1型或2型细胞)经验证,可高效、可靠地用于以下应用:免疫组织化学 (IHC);蛋白质印迹法 (Western Blotting);通过流式细胞分选技术 (FACS) 进行细胞分离;半定量斑点印迹 (Semi-Quantitative Dot Blots);磁性细胞分选 (Magnetic Cell Sorting);冷冻免疫电镜 (TEM Cryo-Immunohistochemistry)。

▍Terracebiotech产品列表
| 品名 | 货号 | Validated For | Production Host | Isotype | 规格 |
| Anti HT1-56 | TB-29AHT1-56 | IHC, Western Blots, FACS, magnetic Cell Sorting, Dot blots, and TEM | Mouse hybridoma cells | Mouse IgG1 | 1ml |
| Anti HT2-280 | TB-27AHT2-280 | IHC, Western Blots, FACS, magnetic Cell Sorting, Dot blots, and TEM | Mouse hybridoma cells | Mouse IgM | 1ml |
| Anti RT1-40 | TB-11ART1-40 | IHC, Western Blots, FACS, magnetic sell sorting, and dot blots. | Mouse hybridoma cells | Mouse IgG1 | 1ml |
| Anti RT2-70 | TB-44ART2-70 | IHC, FACS, magnetic Cell Sorting, and dot blots. | Mouse hybridoma cells | Mouse IgG3 | 1ml |

艾美捷科技代理Emfret品牌。
Emfret是一家专注于免疫学和血液学研究的生物技术公司,以其高质量的抗体和试剂而闻名,特别是在血小板和免疫细胞研究领域。
| Emfret公司的产品与服务 |
● 抗体
血小板抗体:用于检测和研究血小板表面标记和功能。
免疫细胞抗体:用于T细胞、B细胞、单核细胞等免疫细胞的研究。
● 试剂盒
血小板功能检测试剂盒:用于评估血小板活化和聚集。
免疫细胞分型试剂盒:用于多参数流式细胞术分析。
● 定制服务:
抗体开发:根据客户需求开发定制抗体。
试剂盒定制:根据客户需求设计定制试剂盒。
| Emfret产品应用领域 |
● 血液学研究,用于血小板功能和血液疾病研究。
● 免疫学研究,用于免疫细胞表型和功能研究。
● 癌症研究,用于肿瘤免疫微环境和循环肿瘤细胞研究。
● 传染病研究,用于病原体特异性免疫反应研究。
● 临床诊断,支持血液和免疫相关疾病的诊断和监测。
<| 产品列表 |
| Cat.No. | Antigen | Clone | Isotype | Form | Applications | Size |
| C301 | Antibodies for Mouse Platelet Depletion | polyclonal non-immune rat immunoglobulins | Rat IgG | purif. | negative control for #R300 | 0.5 mg |
| D200 | Two-Color Analysis of Mouse Platelet Activation | Wug.E9 JON/A | Rat IgG2b/IgG1 | FITC PE | flow cytometry | 2 x 1.0 ml; 200 tests |
| M011-0 | GPVI | JAQ1 | Rat IgG2a | purif. | IP, IHC, WB | 0.1 mg |
| M011-1 | GPVI | JAQ1 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M021-0 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.H4 | Rat IgG2b | purif. | IP, IHC, block | 0.5 mg |
| M021-1 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.H4 | Rat IgG2b | FITC | FC, IHC | 1.5 ml; 300 tests |
| M022-0 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.A1 | Rat IgG1 | purif. | IP, IHC | 0.5 mg |
| M023-2 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | JON/A | Rat IgG2b | PE | FC (activ. form) | 1.5 ml; 300 tests |
| M024-0 | Integrin alphaIIb (GPIIb, CD41) | MwReg30 | Rat IgG1 | purif. | IP, IHC, generation of Fab fragments | 6 mg |
| M025-0 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.F2 | Rat IgG2a | purif. | IP, IHC | 0.5 mg |
| M025-1 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.F2 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M025-2 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.F2 | Rat IgG2a | PE | FC, IHC | 1.5 ml; 300 tests |
| M025-3 | Integrin alphaIIbbeta3 (GPIIb/IIIa, CD41/CD61) | Leo.F2 | Rat IgG2a | DyLight 649 | FC, IHC | 1.5 ml; 300 tests |
| M030-0 | Integrin beta3 chain (GPIIIa, CD61) | Luc.A5 | Rat IgG2a | purif. | IP, IHC, WB | 0.5 mg |
| M031-0 | Integrin beta3 chain (GPIIIa, CD61) | Luc.H11 | Rat IgG2b | purif. | IP, IHC, WB | 0.5 mg |
| M031-1 | Integrin beta3 chain (GPIIIa, CD61) | Luc.H11 | Rat IgG2b | FITC | FC, IHC | 1.5 ml; 300 tests |
| M040-0 | GPIbalpha (CD42b) | Xia.G5 | Rat IgG2b | purif. | IP, IHC | 0.5 mg |
| M040-1 | GPIbalpha (CD42b) | Xia.G5 | Rat IgG2b | FITC | FC, IHC | 1.5 ml; 300 tests |
| M040-2 | GPIbalpha (CD42b) | Xia.G5 | Rat IgG2b | PE | FC, IHC | 1.5 ml; 300 tests |
| M040-3 | GPIbalpha (CD42b) | Xia.G5 | Rat IgG2b | DyLight 649 | FC, IHC | 1.5 ml; 300 tests |
| M041-0 | GPIbalpha (CD42b) | Xia.H10 | Rat IgG2a | purif. | FC, IHC | 0.5 mg |
| M041-1 | GPIbalpha (CD42b) | Xia.H10 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M042-0 | GPIbalpha (CD42b) | Xia.G7 | Rat IgG1 | purif. | IP, IHC, WB | 0.5 mg |
| M042-1 | GPIbalpha (CD42b) | Xia.G7 | Rat IgG1 | FITC | FC, IHC | 1.5 ml; 300 tests |
| M043-0 | GPIbalpha (CD42b) | Xia.B2 | Rat IgG2a | purif. | IP, IHC, block | 0.5 mg |
| M043-1 | GPIbalpha (CD42b) | Xia.B2 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M050-0 | GPIbbeta (CD42c) | Xia.C3 | Rat IgG2a | purif. | IP, IHC, WB | 0.5 mg |
| M050-1 | GPIbbeta (CD42c) | Xia.C3 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M051-0 | GPIX (CD42a) | Xia.B4 | Rat IgG1 | purif. | IP, IHC | 0.5 mg |
| M051-1 | GPIX (CD42a) | Xia.B4 | Rat IgG1 | FITC | FC, IHC | 1.5 ml; 300 tests |
| M060-1 | GPV (CD42d) | Gon.C2 | Rat IgG1 | FITC | FC, IHC | 1.5 ml; 300 tests |
| M061-0 | GPV (CD42d) | Gon.G6 | Rat IgG2a | purif. | IP, IHC | 0.5 mg |
| M061-1 | GPV (CD42d) | Gon.G6 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M070-0 | Integrin alpha2 chain (CD49b, GPIa) | Sam.G4 | Rat IgG2b | purif. | IP, IHC, block | 0.5 mg |
| M070-1 | Integrin alpha2 chain (CD49b, GPIa) | Sam.G4 | Rat IgG2b | FITC | FC, IHC | 1.5 ml; 300 tests |
| M071-0 | Integrin alpha2 chain (CD49b, GPIa) | Sam.C1 | Rat IgG2b | purif. | IP, IHC | 0.5 mg |
| M071-1 | Integrin alpha2 chain (CD49b, GPIa) | Sam.C1 | Rat IgG2b | FITC | FC, IHC | 1.5 ml; 300 tests |
| M080-0 | Integrin alpha5 chain (CD49e) | Tap.A12 | Rat IgG1 | purif. | IP, IHC | 0.5 mg |
| M080-1 | Integrin alpha5 chain (CD49e) | Tap.A12 | Rat IgG1 | FITC | FC, IHC | 1.5 ml; 300 tests |
| M110-0 | CD9 | Nyn.H3 | Rat IgG2a | purif. | IP, IHC, WB | 0.5 mg |
| M110-1 | CD9 | Nyn.H3 | Rat IgG2a | FITC | FC, IHC | 1.5 ml; 300 tests |
| M120-0 | CD31 (PECAM-1) | Pec.H3 | Rat IgG1 | purif. | IP, IHC, WB | 0.5 mg |
| M130-0 | CD62P (P-selectin) | Wug.E9 | Rat IgG1 | purif. | IP, IHC | 0.5 mg |
| M130-1 | CD62P (P-selectin) | Wug.E9 | Rat IgG1 | FITC | FC, IHC | 1.5 ml; 300 tests |
| M130-2 | CD62P (P-selectin) | Wug.E9 | Rat IgG1 | PE | FC, IHC | 1.5 ml; 300 tests |
| P140-1 | fibrinogen | polyclonal | Rabbit IgG | FITC | FC, IHC | 1.5 ml; 300 tests |
| P150-1 | von Willebrand Factor (vWF) | polyclonal | Rabbit IgG | FITC | FC, IHC | 1.5 ml; 300 tests |
| P180-1 | negative control | polyclonal | Rabbit IgG | FITC | FC, IHC | 1.0 ml; 200 tests |
| P190-1 | negative control | polyclonal | Rat IgG | FITC | FC, IHC | 1.0 ml; 200 tests |
| P190-2 | negative control | polyclonal | Rat IgG | PE | FC, IHC | 1.0 ml; 200 tests |
| P190-3 | negative control | polyclonal | Rat IgG | DyLight 649 | FC, IHC | 1.0 ml; 200 tests |
| R300 | Antibodies for Mouse Platelet Depletion | polyclonal anti-GPIb alpha | Rat IgG | purif. | platelet depletion | 0.5 mg |
| X488 | Antibodies for In Vivo Mouse Platelet Labeling | anti - GPIbbeta derivative | Rat IgG | DyLight 488 | in vivo | 100 µg |
| X649 | Antibodies for In Vivo Mouse Platelet Labeling | anti - GPIbbeta derivative | Rat IgG | DyLight 649 | in vivo | 100 µg |

艾美捷科技代理HycultBiotech全系列产品。
Hycult Biotech是一家专注于设计、研发、生产以及销售抗体和其相关产品的公司,其特色产品是天然免疫及相关领域的免疫分析试剂,例如补体, 嗜中性粒细胞蛋白,TLP,清道夫受体以及急性期蛋白等。除此之外,Hycult Biotech公司也可以提供炎症反应和细胞损伤等方面的产品。
HYCULT BIOTECH的主要产品包括:
Assays
Monoclonal antibodies
Polyclonal antibodies
Disease state human plasma
Proteins
Functional study antibodies
Immunoassay antibodies
Secondary reagents
按照产品领域细分:
Acute phase proteins
Adhesion molecules
Antimicrobial peptides
Cell damage and toxicity
Coagulation molecules
Complement and collectins
Cytokines and chemokines
Granulocyte and lymphocyte proteins
LPS and microbial toxins
Oxidative stress
TLR and inflammasome
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://antylia.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Hycult Biotech"> Hycult Biotech
<艾美捷科技代理Helvetica Health Care品牌全系列产品
Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司,致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员,Helvetica Health Care通过了ISO 13485认证,在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板,适用于不同的分子测试平台和检测。这些产品有多种规格,可用于单一或多种分析物的检测,帮助实验室监控测试性能,确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制,满足不同平台的需求。
▎Helvetica Health Care产品线
Helvetica Health Care公司的产品涵盖:抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。

▎Helvetica Health Care部分产品列表
| 货号 | 产品描述 |
| NATFRC-6C | NATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL) |
| NATCV9-6C | NATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL) |
| NATRPC2.1-BIO | NATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL) |
| NATRVP2.1-BIO | NATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA) |
| NATRVP2.1-BIO Plus | NATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml) |
| NATRVP2-QIA | NATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA) |
| NATSARS(COV2)-VP | NATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL) |
| NATSARS(COV2)-ERC | SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL) |
| NATSARS(COV2)-ERC1 | NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml) |
| NATSARS(COV2)-NEG | SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL) |
| NATSARS(COV2)-NEG1 | NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml) |
| NATSARS(COV2)-ST | SARS-Related Coronavirus 2 (SARS-CoV-2) Stock |
| NATSARS(COV2-SA)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL) |
| NATSARS(COV2-UK)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL) |
| 0810229-0.5mg | Coronavirus 229E Lysate (0.5 mg) |
| 0810587 | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg) |
| 0810587-0.5mg | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg) |
| 0810587CFHI-0.5mL | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL) |
| 0810587CFHI | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL) |
| 0810587UV | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL) |
| 0810589CFHI | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810589UV | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL) |
| 0810590CFHI | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810590UV | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL) |
| 0810617UV | SARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV)) |
| 0810618UV | SARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV) |
| 0810619UV | SARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated) |
| 0810620UV | SARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated) |
| 0810621UV | SARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated) |
| 0810622UV | SARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated) |
| 0810612CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810612UV | SARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL) |
| 0810613CFHI | SARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL) |
| 0810613UV | SARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL) |
| 0810614CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810614UV | SARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL) |
| 0810616CFHI | SARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL) |
| 0810616UV | SARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL) |
| 0810617CFHI | SARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml) |
| 0810618CFHI | SARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml) |
| 0810619CFHI | SARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml) |
| 0810620CFHI | SARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml) |
| 0810621CFHI | SARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml) |
| 0810622CFHI | SARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml) |
| 0810623UV | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated) |
| 0810623CFHI | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated) |
| 0810624UV | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated) |
| 0810624CFHI | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated) |
| 0820010CFHI | VeroE6 Culture Fluid (Heat Inactivated) (1 mL) |
| 0801043 | Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml) |
| 0831042 | SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL) |
| 0831043 | SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL) |
| NATSARS-ST | Coronavirus SARS Stock (Qualitative) (1 mL) |
| NATCOV(229E)-ST | Coronavirus 229E Stock (Qualitative) (1 mL) |
| 0810229CFHI | Coronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810229 | Coronavirus Strain: 229E Lysate |
| 0810229UV | Coronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL) |
| NATCOV(NL63)-ST | Coronavirus NL63 Stock (Qualitative) (1 mL) |
| 0810228CFHI | Coronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810228 | Coronavirus Strain: NL63 Lysate |
| 0810228UV | Coronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL) |
| NATCOV(OC43)-ST | Coronavirus OC43 Stock (Qualitative) (1 mL) |
| 0810024CFHI | Coronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810024 | Coronavirus Strain: OC43 Lysate |
| NATMERS-ST | MERS-CoV Stock (Qualitative) (1 mL) |
| NATMR-BIO | NATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml) |
| NATCOV(MR)-BIO | NATtrol MERS-S. Cerevisiae (0.6 ml) |
| 0810575 | MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg) |
| 0810575-0.5mg | MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg) |
| CV033122 | COVID-19 Cross Over Panel (40x 1.0 ml) |
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:17754422825
传真:18995651644
邮箱:sales@amyjet.com
0.1739